Tag: Neurodegenerative Diseases
Assessing the Cost-Effectiveness of Alzheimer’s Drug Donanemab in the U.K.
The recent decision by the U.K.'s National Institute for Health and Care Excellence (NICE) regarding the cost-effectiveness of the Alzheimer's drug Donanemab, also known as Kisunla, has raised concerns about its accessibility to patients....
Unlocking Faster Dementia Diagnoses Using AI and Brain Waves
Dementia is a growing concern, and Mayo Clinic researchers believe that artificial intelligence (AI) can help with faster and earlier diagnoses. By combining AI with EEG tests, the Mayo Clinic Neurology AI Program (NAIP)...
Accurate Alzheimer’s Diagnosis: Blood Test with 90% Success Rate
Scientists have recently made a significant advancement in the quest for a simple blood test to accurately diagnose Alzheimer's disease. The study, published in the journal JAMA, revealed that the blood test was approximately...